U.S. Hospitality Stock News

NYSE:NNI
NYSE:NNIConsumer Finance

Will Nelnet's (NNI) Strong 2025 Earnings and Project Horizon Leadership Shift Its Narrative?

Nelnet, Inc. reported past fourth-quarter 2025 net income of US$57.77 million, down from US$63.16 million a year earlier, while full-year 2025 net income rose to US$428.47 million and basic earnings per share from continuing operations increased to US$11.79. Alongside these results, Nelnet Campus Commerce appointed Evan Claudeanos as managing director of Product and Engineering to lead Project Horizon, a multi-year platform transformation aimed at strengthening its higher education...
NYSE:ACEL
NYSE:ACELHospitality

A Look At Accel Entertainment’s Valuation After Record 2025 Results And Buyback Completion

Accel Entertainment (ACEL) is back in focus after reporting fourth quarter and full year 2025 results, featuring record revenue, a near doubling of net income, and continued share repurchases that completed a multi year buyback program. See our latest analysis for Accel Entertainment. The earnings release and confirmation of the completed multi year buyback have come after a 90 day share price return of 16.43% and a 1 year total shareholder return of 19.86%. The current share price of $12.19...
NasdaqGM:FLY
NasdaqGM:FLYAerospace & Defense

Firefly Postpones Alpha Relaunch As Block II Shift Weighs On Valuation

Firefly Aerospace postponed its planned Alpha rocket return to flight following a prior mission failure. The delay extends an operational pause that has already lasted about ten months. The company plans to move to an upgraded Block II Alpha configuration after this return to flight mission. For investors watching Firefly Aerospace (NasdaqGM:FLY), the timing of this postponement comes after a tough stretch for the stock. Shares recently closed at $20.38, with a decline of 5.3% over the past...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

DraftKings Super App And Prediction Push Reframe Growth And Valuation Narrative

DraftKings (NasdaqGS:DKNG) announced plans to launch a unified Super App that will bring together its Sportsbook, Predictions, Casino, and Lottery offerings. The company is prioritizing prediction markets as a core focus area, positioning them alongside its existing real money gaming products. Management highlighted the use of AI across the new platform, with the Super App framed as a long term shift in how DraftKings operates and competes. For you as an investor, this move speaks directly...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

How AMD’s Massive Meta AI Deal And Ecosystem Push Has Changed Its Investment Story (AMD)

In late February and early March 2026, AMD and its partners announced a multi-year AI infrastructure deal with Meta worth over US$100 billion, new Ryzen AI 400 Series desktop processors, expanded U.S. manufacturing of Instinct GPU platforms, and fresh collaborations across telecom, cloud and 6G ecosystems. Together, these moves signal AMD’s push to embed its CPUs and GPUs at the core of hyperscale, enterprise, and next-generation network AI workloads, while tying major customers to its...
NasdaqGS:INDB
NasdaqGS:INDBBanks

Assessing Independent Bank (INDB) Valuation After Recent Share Price Pullback

Why Independent Bank is on investors’ radar today Independent Bank (INDB) has drawn fresh attention after recent share price moves, with the stock down about 7% over the past month but higher over the past 3 months and year. See our latest analysis for Independent Bank. After a softer patch that includes a 1-day share price return of 1.27% decline and a 30-day share price return of 7.36% decline, Independent Bank still shows positive momentum over longer periods, with a 1-year total...
NYSE:NJR
NYSE:NJRGas Utilities

Will Strong Q1 Beat and Clean Energy Push Change New Jersey Resources' (NJR) Narrative?

New Jersey Resources recently reported fiscal first-quarter 2026 results that exceeded analyst expectations on both earnings per share and revenue, while also highlighting record US$98 million of energy efficiency investments and its highest annual installed solar capacity in its latest Corporate Sustainability Report. The combination of stronger-than-expected quarterly performance, expanded clean energy and efficiency initiatives, and ongoing investor conference appearances underscores how...
NYSE:ALLE
NYSE:ALLEBuilding

Is Allegion (ALLE) Now Fairly Priced After Recent Share Price Pullback?

If you are wondering whether Allegion's current share price reflects its true worth, this article will walk through what the numbers actually say about its value. After a 21.2% return over the past year and 42.8% over three years, the stock has recently pulled back, with a 5.1% decline over the last week and a 9.3% drop over the past month, and is down 5.4% year to date from a last close of US$152.26. Recent coverage around Allegion has largely focused on its role in the capital goods sector...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Is Rezdiffra’s Rapid Uptake And New Patent Shield Altering The Investment Case For Madrigal (MDGL)?

Madrigal Pharmaceuticals recently reported stronger-than-expected fourth-quarter 2025 revenue driven by rapid adoption of its MASH therapy Rezdiffra, alongside insider share sales by its CFO to cover tax obligations and new equity grants to incoming employees under the 2025 Inducement Plan. The company also secured long-term patent protection for Rezdiffra through 2045 and is preparing for further visibility at the TD Cowen Health Care Conference, developments that may influence how...
NYSE:TTAM
NYSE:TTAMBasic Materials

Is Titan America (TTAM) Offering Value After Recent Share Price Weakness?

If you are wondering whether Titan America is attractively priced or not, you are in the right place to size up what the current share price might be offering you. The stock recently closed at US$16.59, with a 7 day return of 11.7% decline, a 30 day return of 7.7% decline, and a 1 year return of 10.4%, which gives a mixed picture for investors watching both short term swings and the year to date return of 0.7% decline. Recent news coverage has focused on Titan America as a US materials name...
NasdaqGS:CASY
NasdaqGS:CASYConsumer Retailing

A Look At Casey's General Stores (CASY) Valuation After Its Strong Multi Year Shareholder Returns

Casey's General Stores (CASY) is drawing fresh attention after recent share price moves, with the stock now around US$670.91. For investors, the key question is how current performance lines up with fundamentals. See our latest analysis for Casey's General Stores. Recent moves have been mixed, with a 1 day share price return of 1.9% decline and a 7 day share price return of 2.1% decline, set against a 30 day gain of 3.6% and a 90 day rise of 18.3%. At the same time, the 1 year total...
NasdaqGS:EXPO
NasdaqGS:EXPOProfessional Services

A Look At Exponent (EXPO) Valuation After Its Latest Earnings And CEO Commentary

Quarterly earnings beat draws investor attention Exponent (EXPO) has drawn fresh attention after reporting quarterly revenue growth of 4.5% year on year, edging past analyst expectations and pairing that with an earnings beat and positive commentary from CEO Dr. Catherine Corrigan. See our latest analysis for Exponent. The quarterly beat has arrived alongside a 6.3% 30 day share price return and a 5.9% year to date share price gain. However, the 1 year total shareholder return is still an...
NasdaqCM:CORT
NasdaqCM:CORTPharmaceuticals

A Look At Corcept Therapeutics (CORT) Valuation After Legal And FDA Setbacks Reshape Expectations

Earnings and legal developments reshape the Corcept Therapeutics (CORT) story Corcept Therapeutics (CORT) is back in focus after investors digested a mix of legal and regulatory headlines, including a securities class action tied to disclosures around its relacorilant program and the FDA’s rejection of the drug. The lawsuit centers on allegations that Corcept and certain executives misrepresented the strength of clinical evidence for relacorilant in hypercortisolism and the feedback received...
NYSE:NI
NYSE:NIIntegrated Utilities

Assessing NiSource (NI) Valuation As Dividend Growth And 2026 Earnings Outlook Draw Investor Interest

Dividend and earnings outlook puts NiSource (NI) in focus NiSource (NI) is drawing attention after its annualized dividend moved 7.1% higher year over year to a 2.54% yield, along with a Zacks 2026 earnings estimate of US$2.05 per share. See our latest analysis for NiSource. NiSource’s recent dividend increase and 2026 earnings outlook come against a backdrop of steady share price momentum, with an 11.58% year to date share price return and a 25.26% 1 year total shareholder return from a...
NYSE:RVTY
NYSE:RVTYLife Sciences

The Bull Case For Revvity (RVTY) Could Change Following Cautious 2026 Outlook And Capital Allocation Scrutiny

Revvity recently reported past fourth-quarter 2025 results with adjusted earnings of US$1.70 per share on 5.9% revenue growth, while issuing 2026 guidance that aligned with but did not lift already reduced analyst expectations. A contemporaneous Bretton Fund letter criticized Revvity’s use of its Covid testing windfall on overpriced deals and divestitures, highlighting investor unease with management’s capital allocation choices despite the company’s remaining potential. We’ll now examine...
NasdaqCM:ALOY
NasdaqCM:ALOYSoftware

A Look At REalloys (ALOY) Valuation After Sharp Swings In Recent Share Price Performance

REalloys stock performance catches investor attention REalloys (ALOY) has turned heads after a sharp 16.19% decline over the past day, even as the stock shows strong gains over the past week, month, past 3 months, and year to date. See our latest analysis for REalloys. At a share price of $21.69, the 16.19% one day pullback sits against a powerful backdrop, with a 55.26% 7 day share price return, 73.80% 30 day return, and very large 1 year total shareholder return. Together, these figures...
NasdaqGS:IMCR
NasdaqGS:IMCRBiotechs

Assessing Immunocore (IMCR) Valuation After Earnings Show Revenue Growth And Narrower Full Year Loss

Immunocore Holdings (IMCR) is back in focus after its latest earnings report, which showed year over year revenue growth and a smaller full year net loss, prompting investors to reassess the stock. See our latest analysis for Immunocore Holdings. The latest earnings report and upcoming conference schedule have not reversed recent share price pressure. The 90 day share price return of 17.66% and the 3 year total shareholder return of 39.74% point to fading momentum, despite a 1 year total...
NasdaqGS:TTWO
NasdaqGS:TTWOEntertainment

GTA VI Release Date Sets Stage For Take Two Growth Cycle

Take-Two Interactive Software has officially set a release date for Grand Theft Auto VI. The confirmation marks the start of the next major product cycle for the Grand Theft Auto franchise. Investors are assessing how the upcoming title could influence Take-Two Interactive Software's future revenue profile and competitive position. Take-Two Interactive Software, ticker NasdaqGS:TTWO, enters this new phase with its shares recently trading at $212.53. The stock shows mixed recent performance,...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

Is Mercury Systems (MRCY) Pricing Reflect Recent Defense Sector Optimism Accurately

This article is designed to help you assess whether Mercury Systems' current share price aligns with its underlying worth, or whether the market may be getting ahead of itself, and to frame that question clearly. The stock last closed at US$84.96, with a 94.0% return over 1 year and 11.7% year to date, even as the 7 day and 30 day returns were 5.2% and 14.4% declines respectively. Recent news coverage has focused on Mercury Systems as investors reassess defense and aerospace related names,...
NasdaqGS:CMPR
NasdaqGS:CMPRCommercial Services

A Look At Cimpress (CMPR) Valuation After VistaPrint’s New AI Logo Tool Launch

AI Logomaker launch puts Cimpress (CMPR) in focus Cimpress (CMPR), through its VistaPrint brand, has launched AI Logomaker by VistaPrint, a generative AI tool designed to give small businesses personalized, print ready logos from simple prompts. The product is meant to lower branding costs and speed up design work, which could matter to investors watching how Cimpress uses AI within its mass customization printing and digital services platform. See our latest analysis for Cimpress. The AI...
NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

Robinhood Platinum Card Marks Shift Toward Broader Financial Super App

Robinhood Markets (NasdaqGS:HOOD) has launched the Platinum Card, a premium credit card aimed at higher income customers. The company is also rolling out new wealth tools, including an Early Dividends program for eligible investors. These products expand Robinhood’s platform beyond trading into broader credit and wealth services. For a platform best known for commission free stock and options trading, the Platinum Card and Early Dividends program mark a clear broadening of Robinhood’s...
NYSE:VSH
NYSE:VSHElectronic

Vishay Launches New LED And Optocouplers As Valuation Questions Linger

Vishay Intertechnology (NYSE:VSH) introduced a compact tricolor LED aimed at higher reliability and space constrained designs across industrial and consumer uses. The company also launched its VOx619A optocoupler series, designed to support efficiency and durability needs in applications such as micro mobility, energy storage, and automation. These product updates expand Vishay's component portfolio into areas that demand tighter integration, broader temperature tolerance, and long service...
NYSE:CBL
NYSE:CBLRetail REITs

A Look At CBL And Associates Properties’ Valuation After Gateway Mall Deal And Open Air Center Sale

CBL & Associates Properties (CBL) has moved to reshape its retail portfolio by closing the acquisition of Gateway Mall in Lincoln, Nebraska, and agreeing to sell an open-air center to recycle capital into cash-flow-focused assets. See our latest analysis for CBL & Associates Properties. At a share price of US$37.72, CBL & Associates Properties has posted a 3.94% 30 day share price return and a 40.36% 1 year total shareholder return. This suggests recent momentum has added to a much stronger...
NasdaqCM:MLTX
NasdaqCM:MLTXBiotechs

Assessing MoonLake Immunotherapeutics (MLTX) Valuation After Positive Phase 2 Sonelokimab Results

Why the latest sonelokimab data matters for MoonLake Immunotherapeutics (MLTX) MoonLake Immunotherapeutics (NasdaqCM:MLTX) has attracted fresh attention after reporting positive topline Phase 2 results for sonelokimab in axial spondyloarthritis, a clinical update that could reshape how some investors think about the company’s pipeline risk. See our latest analysis for MoonLake Immunotherapeutics. Beyond the latest sonelokimab update, MoonLake’s share price has gained 17.24% over the past 30...